Characteristics of study subjects
AIAR (n=15) | ATAR (n=8) | Controls (n=8) | |
---|---|---|---|
Mean (SD) age/range | 55 (14)/34–70 | 53 (8)/41–64 | 32 (10)/24–53 |
M:F | 6:9 | 5:3 | 6:2 |
FEV1 (% predicted)/range | 64 (22)/27–96 | 81 (12)/58–99 | 88 (3)/81–98 |
Intranasal corticosteroids | |||
No of patients | 14 | 8 | 0 |
Dose (μg/day)/range | 520/400–1000 | 400/200–800 | 0 |
Oral prednisone | |||
No of patients | 4 | 1 | 0 |
Dose (μg/day)/range | 8.3/5–15 | 5 | 0 |
AIAR = aspirin intolerant asthma/rhinitis; ATAR = aspirin tolerant asthma/rhinitis.